Attached files
file | filename |
---|---|
EX-23.1 - EX-23.1 - SteadyMed Ltd. | a14-20867_11ex23d1.htm |
EX-5.1 - EX-5.1 - SteadyMed Ltd. | a14-20867_11ex5d1.htm |
As filed with the Securities and Exchange Commission on March 19, 2015.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form S-1
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
SteadyMed Ltd.
(Exact name of registrant as specified in its charter)
Israel |
|
2834 |
|
Not Applicable |
SteadyMed Ltd.
5 Oppenheimer Street
Rehovot 7670105, Israel
+972-3-6449556
(Address, including zip code, and telephone number,
including area code, of registrants principal executive offices)
Jonathan M.N. Rigby
President and Chief Executive Officer
SteadyMed Therapeutics, Inc.
2410 Camino Ramon
San Ramon, California 94583
(925) 272-4999
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
Copies to:
James C. Kitch |
Einat Katzenell |
Shlomo Landress |
Cheryl V. Reicin |
Chaim Friedland, Adv. |
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. o
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. x 333-201949
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o |
Accelerated filer o |
Non-accelerated filer x |
Smaller reporting company o |
CALCULATION OF REGISTRATION FEE
Title of Each Class of Securities |
|
|
Number of Shares |
|
|
Proposed Maximum |
|
|
Proposed Maximum |
|
|
Amount of |
| |||
Ordinary shares, nominal value NIS 0.01 per share |
|
|
517,500 |
|
|
$ |
8.50 |
|
|
$ |
4,398,750 |
|
|
$ |
511.14 |
|
(1) The ordinary shares being registered pursuant to this Registration Statement are in addition to the 4,887,500 ordinary shares registered pursuant to the Registrants Registration Statement on Form S-1 (Registration No. 333-201949).
(2) Based on the initial public offering price.
EXPLANATORY NOTE AND INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
This Registration Statement on Form S-1 is being filed with the Securities and Exchange Commission (the Commission) pursuant to Rule 462(b) under the Securities Act of 1933, as amended. This Registration Statement incorporates by reference the contents of, including all amendments and exhibits thereto and all information incorporated by reference therein, the Registration Statement on Form S-1 (Registration No. 333-201949), which was declared effective by the Commission on March 19, 2015, and is being filed solely for the purpose of registering an increase in the amount of ordinary shares registered by 517,500 shares. The required opinions and consents are listed on the Exhibit Index attached hereto.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Ramon, California on March 19, 2015.
|
STEADYMED LTD. | |
|
| |
|
| |
|
By: |
/s/ JONATHAN M.N. RIGBY |
|
|
Name: Jonathan M.N. Rigby |
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:
Signature |
|
Title |
|
Date | |
|
|
|
|
| |
|
|
|
|
| |
|
|
President and Chief Executive Office |
|
March 19, 2015 | |
/s/ JONATHAN M.N. RIGBY |
|
(Principal Executive Officer) and |
| ||
Jonathan M.N. Rigby |
|
Authorized Representative in the |
| ||
|
|
United States |
| ||
|
|
|
|
| |
|
|
|
|
| |
/s/ DAVID W. NASSIF |
|
Chief Financial Officer |
|
March 19, 2015 | |
David W. Nassif |
|
(Principal Financial and Accounting Officer) |
| ||
|
|
|
|
| |
* |
|
Director |
|
March 19, 2015 | |
Keith Bank |
| ||||
|
|
|
|
| |
* |
|
Director |
|
March 19, 2015 | |
Stephen J. Farr |
| ||||
|
|
|
|
| |
* |
|
Director |
|
March 19, 2015 | |
Ron Ginor |
| ||||
|
|
|
|
| |
|
|
Director |
|
| |
Donald D. Huffman |
| ||||
|
|
|
|
| |
* |
|
Director |
|
March 19, 2015 | |
Brian J. Stark |
| ||||
|
|
|
|
| |
* |
|
Director |
|
March 19, 2015 | |
William S. Slattery |
| ||||
|
|
|
|
| |
*By: |
/s/ JONATHAN M.N. RIGBY |
|
|
|
|
|
Attorney-in-fact |
|
|
|
|
EXHIBIT INDEX
Exhibit |
|
|
|
Incorporated by Reference |
| ||||||
Number |
|
Exhibit Description |
|
Form |
|
File No. |
|
Exhibit |
|
Filing Date |
|
|
|
|
|
|
|
|
|
|
|
|
|
5.1 |
|
Opinion of Amit, Pollak, Matalon & Co. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.1 |
|
Consent of Independent Registered Public Accounting Firm |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.2 |
|
Consent of Amit, Pollak, Matalon & Co. (included in Exhibit 5.1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24.1 |
|
Power of Attorney |
|
S-1 |
|
333-201949 |
|
Included on signature page |
|
February 6, 2015 |
|